Talphera, Inc. (TLPH)

USD 0.49

(-13.84%)

Long Term Debt Summary of Talphera, Inc.

  • Talphera, Inc.'s latest annual long term debt in 2023 was - USD , down -100.0% from previous year.
  • Talphera, Inc.'s latest quarterly long term debt in 2024 Q2 was 6.52 Million USD , up 3.37% from previous quarter.
  • Talphera, Inc. reported annual long term debt of 2.95 Million USD in 2022, down -66.21% from previous year.
  • Talphera, Inc. reported annual long term debt of 8.75 Million USD in 2021, down -44.39% from previous year.
  • Talphera, Inc. reported quarterly long term debt of 6.31 Million USD for 2024 Q1, down 0.0% from previous quarter.
  • Talphera, Inc. reported quarterly long term debt of - USD for 2023 FY, down -100.0% from previous quarter.

Annual Long Term Debt Chart of Talphera, Inc. (2023 - 2013)

Historical Annual Long Term Debt of Talphera, Inc. (2023 - 2013)

Year Long Term Debt Long Term Debt Growth
2023 - USD -100.0%
2022 2.95 Million USD -66.21%
2021 8.75 Million USD -44.39%
2020 15.74 Million USD -85.97%
2019 112.2 Million USD 16.07%
2018 96.66 Million USD 2.45%
2017 94.35 Million USD 3.84%
2016 90.86 Million USD 13.75%
2015 79.87 Million USD 343.38%
2014 18.01 Million USD 25.42%
2013 14.36 Million USD 0.0%

Peer Long Term Debt Comparison of Talphera, Inc.

Name Long Term Debt Long Term Debt Difference
ANI Pharmaceuticals, Inc. 309.66 Million USD 100.0%
Aquestive Therapeutics, Inc. 91.07 Million USD 100.0%
Collegium Pharmaceutical, Inc. 489.96 Million USD 100.0%
Cosmos Health Inc. 3.03 Million USD 100.0%
Dynavax Technologies Corporation 252.41 Million USD 100.0%
Intra-Cellular Therapies, Inc. 13.32 Million USD 100.0%
Pacira BioSciences, Inc. 513.79 Million USD 100.0%
Sunshine Biopharma, Inc. 539.03 Thousand USD 100.0%
Sunshine Biopharma, Inc. 539.03 Thousand USD 100.0%
SCYNEXIS, Inc. 12.15 Million USD 100.0%
Safety Shot Inc 304.9 Thousand USD 100.0%
China SXT Pharmaceuticals, Inc. 117.12 Thousand USD 100.0%
Alpha Teknova, Inc. 13.25 Million USD 100.0%
Bright Green Corporation 201.78 Thousand USD 100.0%
Esperion Therapeutics, Inc. 501.54 Million USD 100.0%
Embecta Corp. 1.62 Billion USD 100.0%
PainReform Ltd. 30 Thousand USD 100.0%
Journey Medical Corporation 14.62 Million USD 100.0%
Procaps Group, S.A. 28.41 Million USD 100.0%
Theratechnologies Inc. 51.26 Million USD 100.0%
Harrow Health, Inc. 183.17 Million USD 100.0%
Sonoma Pharmaceuticals, Inc. 87 Thousand USD 100.0%
Biofrontera Inc. 804 Thousand USD 100.0%
DURECT Corporation 2.7 Million USD 100.0%
Supernus Pharmaceuticals, Inc. 33.19 Million USD 100.0%
Cronos Group Inc. 1.55 Million USD 100.0%
OptiNose, Inc. 611 Thousand USD 100.0%
Ironwood Pharmaceuticals, Inc. 498.3 Million USD 100.0%
Kala Pharmaceuticals, Inc. 34.19 Million USD 100.0%
RedHill Biopharma Ltd. 455 Thousand USD 100.0%
Organogenesis Holdings Inc. 60.74 Million USD 100.0%
Guardion Health Sciences, Inc. - USD NaN%
Cumberland Pharmaceuticals Inc. 12.78 Million USD 100.0%
Radius Health, Inc. 339.66 Million USD 100.0%
Universe Pharmaceuticals INC - USD NaN%
ProPhase Labs, Inc. 10.25 Million USD 100.0%
Phibro Animal Health Corporation 458.28 Million USD 100.0%
Procaps Group S.A. 28.41 Million USD 100.0%
Alvotech 1.02 Billion USD 100.0%
TherapeuticsMD, Inc. 6.53 Million USD 100.0%
Viatris Inc. 16.18 Billion USD 100.0%
Rockwell Medical, Inc. 8.29 Million USD 100.0%
Aytu BioPharma, Inc. 10.87 Million USD 100.0%
SIGA Technologies, Inc. 335.99 Thousand USD 100.0%
Tilray Brands, Inc. 287.93 Million USD 100.0%
Lifecore Biomedical, Inc. 120.51 Million USD 100.0%
Shineco, Inc. 10.01 Million USD 100.0%
PetIQ, Inc. 437.82 Million USD 100.0%
Regencell Bioscience Holdings Limited - USD NaN%
Incannex Healthcare Limited 210 Thousand USD 100.0%
Neurocrine Biosciences, Inc. 258.3 Million USD 100.0%
Alimera Sciences, Inc. 64.48 Million USD 100.0%
Silver Spike Investment Corp. - USD NaN%
Assertio Holdings, Inc. 38.51 Million USD 100.0%
Shuttle Pharmaceuticals Holdings, Inc. 135.08 Thousand USD 100.0%
Petros Pharmaceuticals, Inc. 6.85 Million USD 100.0%
Clever Leaves Holdings Inc. 720 Thousand USD 100.0%
Cyclo Therapeutics, Inc. 22.48 Thousand USD 100.0%
Avadel Pharmaceuticals plc 32.75 Million USD 100.0%
Hempacco Co., Inc. 5.93 Million USD 100.0%
Alvotech 1.02 Billion USD 100.0%
Eagle Pharmaceuticals, Inc. 56.21 Million USD 100.0%
Lantheus Holdings, Inc. 616.12 Million USD 100.0%
Currenc Group, Inc. 2.5 Million USD 100.0%
Kamada Ltd. 7.43 Million USD 100.0%
Indivior PLC 235.66 Million USD 100.0%
Evoke Pharma, Inc. 5 Million USD 100.0%
Flora Growth Corp. 942 Thousand USD 100.0%
Cyclo Therapeutics, Inc. 22.48 Thousand USD 100.0%
Evolus, Inc. 120.35 Million USD 100.0%
HUTCHMED (China) Limited 48.18 Million USD 100.0%
Amphastar Pharmaceuticals, Inc. 589.19 Million USD 100.0%
Akanda Corp. 2.49 Million USD 100.0%